PERSONALIZED APROACH TO POSTOPERATIVE CHEMOTHERAPY IN THE COMBINED MODALITY TREATMENT OF NON-SMALL CELL LUNG CANCER (CLINICAL CASE)

PERSONALIZED APROACH TO POSTOPERATIVE CHEMOTHERAPY IN THE COMBINED MODALITY TREATMENT OF NON-SMALL CELL LUNG CANCER (CLINICAL CASE)

We present a clinical case of non-small cell lung cancer treated with personalized adjuvant chemotherapy. The expression levels of drug resistance genes, such as ABCC5, RRM1, ERCC1, TOP1, TOP2a, TUBB3 and TYMS in tumor tissue from non-small cell lung cancer were used as predictive markers. This case...

Full description

Saved in:
Bibliographic Details
Main Authors: E. O. Rodionov, S. V. Miller, M. M. Tsyganov, O. V. Cheremisina, S. A. Tuzikov, N. V. Litvyakov, I. G. Frolova, S. A. Velichko, P. I. Lukyanenok, T. V. Polishchuk
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2016-07-01
Series:Сибирский онкологический журнал
Subjects:
combination therapy
lung cancer
an individual approach
drug resistance genes
adjuvant chemotherapy
Online Access:https://www.siboncoj.ru/jour/article/view/357
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items